RecruitingNCT05342740
Study of Biomarkers in Diabetic Chronic Wounds
A Multicenter Case Control Study of Biomarkers in Diabetic Chronic Wounds Based on Combined Multi-omics Analysis Techniques
Sponsor
Yibing Wang
Enrollment
930 participants
Start Date
Jul 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to discover, verify and evaluate the potential biomarkers with regard to the diagnosis, prognostic and/or prediction of diabetic chronic wounds.
Eligibility
Min Age: 18 YearsMax Age: 75 Years
Inclusion Criteria5
- Age between 18 and 75;
- Signed the informed consent form；
- Subjects in the ND group are the healthy participants without diabetes；
- Subjects in the NWD group are the diabetic participants without newly identified wounds；
- Subjects in the CWD group are the diabetic participants with chronic wounds
Exclusion Criteria2
- With sever acute underlying diseases of the brain, heart, lungs, liver and/or kidney;
- No diabetes but combined with lower limb arterial stenosis, occlusion or other conditions affecting wound healing or other causes of wounds such as varicose veins in the lower limbs;
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERcollect whole blood, urine and stool samples
collect whole blood, urine and stool samples
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05342740
Related Trials
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
NCT070111472 locations
Swiss Diabetes Registry - SwissDiab Study
NCT011798154 locations
Genetic Studies of Insulin and Diabetes
NCT000019871 location
Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients
NCT058808101 location
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
NCT0753317574 locations